Advisory Committee on Immunization Practices (ACIP): Meeting, 25318 [E7-8590]

Download as PDF 25318 Federal Register / Vol. 72, No. 86 / Friday, May 4, 2007 / Notices E05, Atlanta, GA 30333, telephone 404.639.6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E7–8617 Filed 5–3–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP): Meeting cprice-sewell on DSK89S0YB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned Federal Advisory Committee: Times and Dates: 8 a.m.—6 p.m., June 27, 2007. 8 a.m.—4 p.m., June 28, 2007. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Global Communications Center, Building 19, Room 232, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Meeting space accommodates approximately 330 people. Overflow space for real-time viewing will be available. Purpose: The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters to be Discussed: The agenda will include discussions on vaccine financing; Hepatitis A post-exposure prophylaxis which will include a VFC vote; cold adapted influenza vaccine; immunization safety; TDap-IPV-Hib combination vaccine (Pentacel); MCV4 dose to 2 years; vaccine shortages; economic analyses of vaccines; evidence-based recommendations; Human Papillomavirus Vaccine; update on HIV vaccines; childhood immunization schedule; adult immunization schedule; update on pneumococcal vaccines working group; update on vaccines during pregnancy and breastfeeding working group; Hepatitis B update on adult recommendations; and agency updates. VFC votes will be taken to VerDate Nov<24>2008 14:51 Apr 20, 2010 Jkt 220001 add Pentacel to the Diphtheria, Tetanus, Pertussis resolution; to the Haemophilus influenzae type b resolution and to the Polio resolution pending Food and Drug Administration approval for licensure of Pentacel. Agenda items are subject to change as priorities dictate. Additional Information: In order to expedite the security clearance process at the CDC Roybal Campus located on Clifton Road, all ACIP attendees are required to register online at www.cdc.gov/nip/acip, which can be found at the ‘‘Upcoming Meetings’’ tab. Please complete all the required fields before submitting your registration and submit no later than May 31, 2007. Please Note: In addition to completing the registration form online, as described above, all non-U.S. citizens are required to complete the ‘‘Access Request Form.’’ The completed access request form should be sent by e-mail directly to Ms. Gardner at dgardner@cdc.gov. Contact Person For More Information: Demetria Gardner, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE, (E–05), Atlanta, Georgia 30333, telephone 404/639–8836, fax 404/639–6258. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: April 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E7–8590 Filed 5–3–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Health Department Subcommittee of the Board of Scientific Counselors (BSC), CDC, National Center for Environmental Health (NCEH)/Agency for Toxic Substances and Disease Registry (ATSDR): Teleconference Meeting. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention, NCEH/ATSDR announces the following subcommittee teleconference meeting: Times and Dates: 12:30 p.m.–2 p.m., June 4, 2007. Place: Century Center, 1825 Century Boulevard, Atlanta, Georgia 30345. Status: Open to the public. Teleconference access limited only by availability of telephone ports. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Purpose: Under the charge of the Board of Scientific Counselors, NCEH/ ATSDR, the HDS Subcommittee will provide the BSC, NCEH/ATSDR with advice and recommendations on local and state health department issues and concerns that pertain to the mandates and mission of NCEH/ATSDR. Matters To Be Discussed: The meeting will include a review of the agenda; approval of minutes from the last conference call; a discussion of recommendations, work plan and comments from the BSC; public comment and the next steps for the HDS. Items are subject to change as priorities dictate. SUPPLEMENTARY INFORMATION: This teleconference meeting is scheduled to begin at 12:30 p.m. Eastern Daylight Savings Time. To participate, please dial 877/315–6535 and enter conference code 383520. The public comment period is scheduled from 1:20–1:30 p.m. FOR FURTHER INFORMATION CONTACT: Shirley D. Little, Committee Management Specialist, NCEH/ATSDR, 1600 Clifton Road, Mail Stop E–28, Atlanta, GA 30303; telephone 404/498– 0615, fax 404/498–0059; E-mail: slittle@cdc.gov. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–8561 Filed 5–3–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–R–244, CMS– 18F5, CMS–417, and CMS–724] Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 72, Number 86 (Friday, May 4, 2007)]
[Notices]
[Page 25318]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8590]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP): Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
Federal Advisory Committee:

    Times and Dates: 8 a.m.--6 p.m., June 27, 2007. 8 a.m.--4 p.m., 
June 28, 2007.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE., Global Communications Center, Building 19, Room 232, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
Meeting space accommodates approximately 330 people. Overflow space 
for real-time viewing will be available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include discussions on 
vaccine financing; Hepatitis A post-exposure prophylaxis which will 
include a VFC vote; cold adapted influenza vaccine; immunization 
safety; TDap-IPV-Hib combination vaccine (Pentacel); MCV4 dose to 2 
years; vaccine shortages; economic analyses of vaccines; evidence-
based recommendations; Human Papillomavirus Vaccine; update on HIV 
vaccines; childhood immunization schedule; adult immunization 
schedule; update on pneumococcal vaccines working group; update on 
vaccines during pregnancy and breastfeeding working group; Hepatitis 
B update on adult recommendations; and agency updates. VFC votes 
will be taken to add Pentacel to the Diphtheria, Tetanus, Pertussis 
resolution; to the Haemophilus influenzae type b resolution and to 
the Polio resolution pending Food and Drug Administration approval 
for licensure of Pentacel. Agenda items are subject to change as 
priorities dictate.
    Additional Information: In order to expedite the security 
clearance process at the CDC Roybal Campus located on Clifton Road, 
all ACIP attendees are required to register online at www.cdc.gov/nip/acip, which can be found at the ``Upcoming Meetings'' tab. 
Please complete all the required fields before submitting your 
registration and submit no later than May 31, 2007.

    Please Note: In addition to completing the registration form 
online, as described above, all non-U.S. citizens are required to 
complete the ``Access Request Form.'' The completed access request 
form should be sent by e-mail directly to Ms. Gardner at 
dgardner@cdc.gov.

    Contact Person For More Information: Demetria Gardner, 
Immunization Services Division, National Center for Immunization and 
Respiratory Diseases, CDC, 1600 Clifton Road, NE, (E-05), Atlanta, 
Georgia 30333, telephone 404/639-8836, fax 404/639-6258.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: April 27, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention.
[FR Doc. E7-8590 Filed 5-3-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.